SkinBioTherapeutics PLC (SBTX) · 2026-11-10

Directorate change

SkinBioTherapeutics has appointed Gill Whitty-Collins as a Non-Executive Director and Chair of its Remuneration Committee, adding consumer-brand experience to the board.

SkinBioTherapeutics PLC (SBTX) · 2026-09-22

Trading Statement

SkinBioTherapeutics has made its interim CEO and Chair permanent as it reports FY27 trading ahead of internal expectations. FY26 revenue is expected to reach £4.7m, but year-end cash fell to £1.5m following losses and investigation-related costs.

SkinBioTherapeutics plc (SBTX) · 2026-08-24

Appointment of Interim CFO

SkinBioTherapeutics has appointed Anita Slater as Interim CFO, not on the Board, for an initial six-month term, effective immediately, to support an orderly finance handover.